166 related articles for article (PubMed ID: 28230853)
1. Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression.
Yoo HS; Lee K; Na K; Zhang YX; Lim HJ; Yi T; Song SU; Jeon MS
Cell Death Dis; 2017 Feb; 8(2):e2632. PubMed ID: 28230853
[TBL] [Abstract][Full Text] [Related]
2. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
Kimball SR; Siegfried BA; Jefferson LS
J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
[TBL] [Abstract][Full Text] [Related]
3. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
5. Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide.
Bauchart-Thevret C; Cui L; Wu G; Burrin DG
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E899-909. PubMed ID: 20841502
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
Lang CH; Frost RA
J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
[TBL] [Abstract][Full Text] [Related]
8. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance.
Ghosh J; Kobayashi M; Ramdas B; Chatterjee A; Ma P; Mali RS; Carlesso N; Liu Y; Plas DR; Chan RJ; Kapur R
J Clin Invest; 2016 Jul; 126(7):2621-5. PubMed ID: 27294524
[TBL] [Abstract][Full Text] [Related]
9. CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation.
Shuda M; Velásquez C; Cheng E; Cordek DG; Kwun HJ; Chang Y; Moore PS
Proc Natl Acad Sci U S A; 2015 May; 112(19):5875-82. PubMed ID: 25883264
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
11. Restorative Mechanisms Regulating Protein Balance in Skeletal Muscle During Recovery From Sepsis.
Crowell KT; Soybel DI; Lang CH
Shock; 2017 Apr; 47(4):463-473. PubMed ID: 27749759
[TBL] [Abstract][Full Text] [Related]
12. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
Bishop JD; Nien WL; Dauphinee SM; Too CK
J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
[TBL] [Abstract][Full Text] [Related]
13. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1.
Fang Y; Park IH; Wu AL; Du G; Huang P; Frohman MA; Walker SJ; Brown HA; Chen J
Curr Biol; 2003 Dec; 13(23):2037-44. PubMed ID: 14653992
[TBL] [Abstract][Full Text] [Related]
14. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
[TBL] [Abstract][Full Text] [Related]
15. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
[TBL] [Abstract][Full Text] [Related]
16. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
Cai ZF; Deng L; Wang MM; Zhang JQ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966
[No Abstract] [Full Text] [Related]
17. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
18. L-Glutamine enhances enterocyte growth via activation of the mTOR signaling pathway independently of AMPK.
Yi D; Hou Y; Wang L; Ouyang W; Long M; Zhao D; Ding B; Liu Y; Wu G
Amino Acids; 2015 Jan; 47(1):65-78. PubMed ID: 25280462
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.
Wu XB; Liu Y; Wang GH; Xu X; Cai Y; Wang HY; Li YQ; Meng HF; Dai F; Jin JD
Sci Rep; 2016 Feb; 6():21420. PubMed ID: 26892992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]